Automated Phonocardiography Analysis in Adults
- Conditions
- Aortic InsufficiencyAortic StenosisInsufficiency, PulmonaryMitral InsufficiencyTricuspid RegurgitationMitral Insufficiency and Aortic StenosisInsufficiency, Tricuspid
- Registration Number
- NCT03600051
- Lead Sponsor
- CSD Labs GmbH
- Brief Summary
Background: Computer aided auscultation in the differentiation of pathologic (AHA class I) from no- or innocent murmurs (AHA class III) via artificial intelligence algorithms could be a useful tool to assist healthcare providers in identifying pathological heart murmurs and may avoid unnecessary referrals to medical specialists.
Objective: Assess the quality of the artificial intelligence (AI) algorithm that autonomously detects and classifies heart murmurs as either pathologic (AHA class I) or as no- or innocent (AHA class III).
Hypothesis: The algorithm used in this study is able to analyze and identify pathologic heart murmurs (AHA class I) in an adult population with valve defects with a similar sensitivity compared to medical specialist.
Methods: Each patient is auscultated and diagnosed independently by a medical specialist by means of standard auscultation. Auscultation findings are verified via gold-standard echocardiogram diagnosis. For each patient, a phonocardiogram (PCG) - a digital recording of the heart sounds - is acquired. The recordings are later analyzed using the AI algorithm. The algorithm results are compared to the findings of the medical professionals as well as to the echocardiogram findings.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- Adults with a heart defect verified by echocardiography
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity for pathological heart murmur detection 2 months Ability to detect a pathological heart murmur in digital heart sound recordings obtained from an elderly population with heart valve disease.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital
🇦🇹Graz, Styria, Austria